Pomegranate’s Neuroprotective Effects against Alzheimer’s Disease Are Mediated by Urolithins, Its Ellagitannin-Gut Microbial Derived Metabolites
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Pomegranate shows neuroprotective effects against Alzheimer's disease (AD) in several reported animal studies. However, whether its constituent ellagitannins and/or their physiologically relevant gut microbiota-derived metabolites, namely, urolithins (6H-dibenzo[b,d]pyran-6-one derivatives), are the responsible bioactive constituents is unknown. Therefore, from a pomegranate extract (PE), previously reported by our group to have anti-AD effects in vivo, 21 constituents, which were primarily ellagitannins, were isolated and identified (by HPLC, NMR, and HRESIMS). In silico computational studies, used to predict blood-brain barrier permeability, revealed that none of the PE constituents, but the urolithins, fulfilled criteria required for penetration. Urolithins prevented β-amyloid fibrillation in vitro and methyl-urolithin B (3-methoxy-6H-dibenzo[b,d]pyran-6-one), but not PE or its predominant ellagitannins, had a protective effect in Caenorhabditis elegans post induction of amyloid β(1-42) induced neurotoxicity and paralysis. Therefore, urolithins are the possible brain absorbable compounds which contribute to pomegranate's anti-AD effects warranting further in vivo studies on these compounds.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rather, a growing consensus is that dietary polyphenols are metabolized by microbiota in the colon to yield bioactive gut microbial metabolites [12,13,14,15,16].”
From Polyphenol Microbial Metabolites Exhibit Gut and Blood–Brain Barrier Permeability and Protect Murine Microglia against LPS-Induced Inflammation (2019) · cites this paper as [12]
Citations
Cites
Interaction between Phenolics and Gut Microbiota: Role in Human Health
Selma, M. V., Espín, J. C., & Tomás-Barberán, F. A. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf902107d · Cited by 1,324
Conformational constraints for amyloid fibrillation: the importance of being unfolded
Uversky, V. N., & Fink, A. L. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.12.008 · Cited by 1,015
2011 Alzheimer's disease facts and figures
Alzheimer's Association (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.02.004 · Cited by 908
Landete, J. M. (2011) · Food Research International · doi:10.1016/j.foodres.2011.04.027 · Cited by 725
Espín, J. C., Larrosa, M., García-Conesa, M. T., & Tomás-Barberán, F. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/270418 · Cited by 576
Antioxidant compounds from bananas (Musa Cavendish)
Someya, S., Yoshiki, Y., & Okubo, K. (2002) · Food Chemistry · doi:10.1016/s0308-8146(02)00186-3 · Cited by 492
Seeram, N. P., Henning, S. M., Zhang, Y., Suchard, M., Li, Z., & Heber, D. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.10.2481 · Cited by 475
Self-citationSloane, P. D., Zimmerman, S., Suchindran, C., Reed, P., Wang, L., Boustani, M., & Sudha, S. (2002) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.23.100901.140525 · Cited by 461
Tomás-Barberán, F. A., García-Villalba, R., González-Sarrías, A., Selma, M. V., & Espín, J. C. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf5024615 · Cited by 419
Hartman, R. E., Shah, A., Fagan, A. M., Schwetye, K. E., Parsadanian, M., Schulman, R. N., Finn, M. B., & Holtzman, D. M. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.006 · Cited by 357
Research works printed but not linked: 4
- Tomás-Barberan F. A., 2009, Flavonoids and Related Compounds: Bioavailability and Function, 183
- Seeram N. P., 2006, Pomegranate: Ancient roots to modern medicine, 3
- Zhexiong J., 2014, J. Chem. Pharm. Res., 6, 1770
- de Fátima Bezerra M., 2014, Int. J. Appl. Res. Nat. Prods., 7, 39
Cited by
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases
Quigley, E. M. M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0802-6 · Cited by 804
The gut microbiota: a key factor in the therapeutic effects of (poly)phenols
Espín, J. C., González-Sarrías, A., & Tomás-Barberán, F. A. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.033 · Cited by 603
Tomás‐Barberán, F. A., González‐Sarrías, A., García‐Villalba, R., Núñez‐Sánchez, M. A., Selma, M. V., García‐Conesa, M. T., & Espín, J. C. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500901 · Cited by 465
Interactions of gut microbiota with dietary polyphenols and consequences to human health
Tomás-Barberán, F. A., Selma, M. V., & Espín, J. C. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000314 · Cited by 351
“survey has shown the potential effects of urolithins in an Alzheimer’s disease model in Caenorhabditis elegans and mice by preventing neuronal inflammation [36].”
BackgroundUrolithins: a Comprehensive Update on their Metabolism, Bioactivity, and Associated Gut Microbiota
García‐Villalba, R., Giménez‐Bastida, J. A., Cortés‐Martín, A., Ávila‐Gálvez, M. Á., Tomás‐Barberán, F. A., Selma, M. V., Espín, J. C., & González‐Sarrías, A. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202101019 · Cited by 302
Metadata
- Authors
- Yuan, T., Ma, H., Liu, W., Niesen, D. B., Shah, N., Crews, R., Rose, K. N., Vattem, D. A., & Seeram, N. P.
- Affiliations
- University of Rhode Island (US)
- Texas State University (US)
- Corresponding author
- Seeram, Navindra P.
- Venue
- ACS Chemical Neuroscience
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-11-17
- Volume
- 7
- Issue
- 1
- Pages
- 26-33
- ISSN
- 1948-7193 (ISSN-L)
- OpenAlex
- W2270905116
- Cited by
- 219
- References
- 44
- Citations by year
- 2026: 13 · 2025: 13 · 2024: 14 · 2023: 19 · 2022: 31 · 2021: 39 · 2020: 33 · 2019: 26 · 2018: 12 · 2017: 11 · 2016: 7
- FWCI
- 9.63
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by
- Locations
- ACS Chemical Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Journal of Media Literacy Education (submittedVersion, cc-by)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Pomegranate: compositions and health benefits
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Keywords
- Punica granatum, Alzheimer's disease, neuroprotection, urolithins, ellagitannins, gut microbiota metabolites, amyloid-beta fibrillation, blood-brain barrier permeability, Caenorhabditis elegans, neurotoxicity, bioactive compounds
- MeSH terms
- Age Factors, Alzheimer Disease, Animals, Biophysics, Blood-Brain Barrier, Chromatography, Liquid, Computer Simulation, Coumarins, Disease Models, Animal, Dose-Response Relationship, Drug, Humans, Models, Biological, Peptide Fragments, Mass Spectrometry, Amyloid beta-Peptides, Caenorhabditis elegans, Neuroprotective Agents, Lythraceae, Animals, Genetically Modified, Hydrolyzable Tannins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pomegranate’s Neuroprotective Effects against Alzheimer’s Disease Are Mediated by Urolithins, Its Ellagitannin-Gut Microbial Derived Metabolites. https://app.cochat.ai/papers/10.1021/acschemneuro.5b00260
- The paper
- Yuan, T., Ma, H., Liu, W., Niesen, D. B., Shah, N., Crews, R., Rose, K. N., Vattem, D. A., & Seeram, N. P. (2016). Pomegranate’s Neuroprotective Effects against Alzheimer’s Disease Are Mediated by Urolithins, Its Ellagitannin-Gut Microbial Derived Metabolites. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5b00260
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.